My Portfolio
+
LINK YOUR PORTFOLIO

Madrigal Pharmaceuticals Inc MDGL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
488.15UNCH (UNCH)
Volume
4,240
Close
488.15quote price arrow up+35.29 (+7.79%)
Volume
260,013
52 week range
268.69 - 615.00
Loading...
  • Open450.61
  • Day High490.12
  • Day Low445.20
  • Prev Close452.86
  • 52 Week High615.00
  • 52 Week High Date12/24/25
  • 52 Week Low268.69
  • 52 Week Low Date06/03/25

Latest On Madrigal Pharmaceuticals Inc

Key Stats

  • Market Cap11.255B
  • Shares Out23.06M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta-1.05

Latest On Madrigal Pharmaceuticals Inc

KEY STATS

  • Open450.61
  • Day High490.12
  • Day Low445.20
  • Prev Close452.86
  • 52 Week High615.00
  • 52 Week High Date12/24/25
  • 52 Week Low268.69
  • 52 Week Low Date06/03/25
  • Market Cap11.255B
  • Shares Out23.06M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta-1.05

RATIOS/PROFITABILITY

  • EPS (TTM)-13.63
  • P/E (TTM)-35.81
  • Fwd P/E (NTM)-156.56
  • EBITDA (TTM)-311.996M
  • ROE (TTM)-49.35%
  • Revenue (TTM)1.132B
  • Gross Margin (TTM)93.07%
  • Net Margin (TTM)-27.32%
  • Debt To Equity (MRQ)62.62%

EVENTS

  • Earnings Date08/03/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Madrigal Pharma CEO talks competition in the liver disease treatment space
VIDEO4:3004:30
Madrigal Pharma CEO talks competition in the liver disease treatment space

Profile

MORE
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. The Company’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-b agonist designed to target key underlying causes of MASH. Rezdiffra is the medication approved by the United States Food and Drug Administration (FDA) for the...
Julian Baker
Independent Chairman of the Board
Bill Sibold
President, Chief Executive Officer, Director
Mardi Dier
Chief Financial Officer, Executive Vice President
Carole Huntsman
Executive Vice President, Chief Commercial Officer
David Soergel M.D.
Executive Vice President, Chief Medical Officer
Address
200 Barr Harbor Drive, Suite 400
West Conshohocken, PA
19428
United States